Add to ORKGand efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoeti
Anemia is prevalent in patients withstage V chronic kidney disease (CKD) undergoing hemodialysis (HD...
Anaemia is a frequent consequence of chronic kidney disease (CKD) that is linked to a worse quality ...
End-stage renal failure patients are normally anaemic due to failure of renal to produce endogenous ...
Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group has produced comprehensive cli...
The optimal treatment of renal anaemia—OPTA—is an initiative aiming to improve anaemia care manage-m...
Anemia in Chronic Kidney Disease (CKD) is present in approximately 90% of patients with glomerular f...
Cardiovascular disease is a significant complication in chronic kidney disease (CKD) and a major cau...
The administration of recombinant human erythropoietin (EPO) has considerably improved renal anemia ...
Anemia develops in early stages of CKD and is nearly universal in patients with end stage kidney...
The anemia of end stage renal disease (ESRD) is common and often severe complication that can be man...
haemodiafiltration more favourable than haemodialysis for treatment of renal anaemia
Anaemia correction with recombinant human erythro-poietin (rh-EPO, epoetin) in end-stage renal disea...
Improving anemia by hemodialysis: Effect on serum erythropoietin. Serum erythropoietin (SEP) concent...
The studies have shown that the major pathogenetic factor in the development of anemia was an absolu...
Abstract Anaemia is a commonly diagnosed complication among patients suffering with chronic kidney d...
Anemia is prevalent in patients withstage V chronic kidney disease (CKD) undergoing hemodialysis (HD...
Anaemia is a frequent consequence of chronic kidney disease (CKD) that is linked to a worse quality ...
End-stage renal failure patients are normally anaemic due to failure of renal to produce endogenous ...
Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group has produced comprehensive cli...
The optimal treatment of renal anaemia—OPTA—is an initiative aiming to improve anaemia care manage-m...
Anemia in Chronic Kidney Disease (CKD) is present in approximately 90% of patients with glomerular f...
Cardiovascular disease is a significant complication in chronic kidney disease (CKD) and a major cau...
The administration of recombinant human erythropoietin (EPO) has considerably improved renal anemia ...
Anemia develops in early stages of CKD and is nearly universal in patients with end stage kidney...
The anemia of end stage renal disease (ESRD) is common and often severe complication that can be man...
haemodiafiltration more favourable than haemodialysis for treatment of renal anaemia
Anaemia correction with recombinant human erythro-poietin (rh-EPO, epoetin) in end-stage renal disea...
Improving anemia by hemodialysis: Effect on serum erythropoietin. Serum erythropoietin (SEP) concent...
The studies have shown that the major pathogenetic factor in the development of anemia was an absolu...
Abstract Anaemia is a commonly diagnosed complication among patients suffering with chronic kidney d...
Anemia is prevalent in patients withstage V chronic kidney disease (CKD) undergoing hemodialysis (HD...
Anaemia is a frequent consequence of chronic kidney disease (CKD) that is linked to a worse quality ...
End-stage renal failure patients are normally anaemic due to failure of renal to produce endogenous ...